Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMNN | IMUNON INC | $12.61M | $0.00 | -$15.03M | -$15.75M | -$14.90 | N/A | -100.00% | N/A | N/A | |||
| ACXP | ACURX PHARMACEUTICALS INC | $6.83M | $0.00 | -$10.00M | -$10.00M | -$10.69 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $22.75M | $0.00 | -$12.55M | -$13.22M | -$0.36 | N/A | N/A | N/A | N/A | |||
| MRSN | MERSANA THERAPEUTICS INC | $35.63M | $34.77M | -$65.59M | -$74.04M | -$14.62 | 16.14% | 83.02% | N/A | N/A | 2025-11-11 | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $68.35M | $0.00 | -$30.97M | -$31.56M | -$3.62 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $10.68M | $1.70M | -$18.54M | -$21.11M | -$0.91 | 61.97% | N/A | N/A | N/A | 2025-11-06 | ||
| PSTV | PLUS THERAPEUTICS INC | $44.67M | $5.32M | -$14.57M | -$19.03M | -$2.03 | -3.49% | -3.22% | N/A | N/A | |||
| REE | REE AUTOMOTIVE LTD | $16.16M | $183.00k | -$98.70M | -$111.75M | -$7.01 | -88.62% | -23.11% | N/A | N/A | 2025-11-12 | ||
| CODX | CO-DIAGNOSTICS INC | $13.14M | $1.00M | -$34.67M | -$35.99M | -$1.15 | -89.02% | -47.74% | N/A | N/A | 2025-11-06 | ||
| CBUS | CIBUS INC | $73.76M | $4.85M | -$234.61M | -$275.33M | -$10.08 | 63.66% | -15.75% | N/A | N/A | |||
| CLSD | CLEARSIDE BIOMEDICAL INC | $24.87M | $1.43M | -$29.81M | -$30.81M | -$0.41 | -82.56% | -25.44% | N/A | N/A | |||
| MBRX | MOLECULIN BIOTECH INC | $11.02M | $0.00 | -$26.43M | -$26.55M | -$3.52 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $152.36M | $81.71M | -$55.42M | -$64.59M | -$0.29 | 565.52% | -6.02% | N/A | N/A | 2025-10-30 | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $28.77M | $1.20M | -$22.18M | -$29.80M | -$0.99 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| MTVA | METAVIA INC | $16.84M | $0.00 | -$18.47M | -$18.49M | -$1.49 | N/A | N/A | N/A | N/A | |||
| FGEN | FIBROGEN INC | $48.65M | -$72.84M | $2.18M | -$2.07M | -$0.38 | N/A | N/A | N/A | N/A | |||
| GRI | GRI BIO INC | $4.55M | $0.00 | -$10.02M | -$11.92M | $3.81 | N/A | N/A | -99.72% | N/A | |||
| GOVX | GEOVAX LABS INC | $17.80M | $0.00 | -$24.71M | -$24.81M | -$2.01 | N/A | -100.00% | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $55.17M | $0.00 | -$33.79M | -$33.79M | -$2.24 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $18.83M | $1.00M | -$20.10M | -$19.31M | -$2.30 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| IMUX | IMMUNIC INC | $76.08M | $0.00 | -$96.19M | -$96.40M | -$0.95 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| XFOR | X4 PHARMACEUTICALS INC | $18.87M | $31.36M | $26.84M | $14.60M | $2.14 | N/A | 59.90% | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.79M | $0.00 | -$8.43M | -$8.43M | -$0.21 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| JSPR | JASPER THERAPEUTICS INC | $39.50M | $0.00 | -$88.84M | -$90.92M | -$6.03 | N/A | N/A | N/A | N/A | |||
| MDCX | MEDICUS PHARMA LTD | $42.94M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | |||
| INTS | INTENSITY THERAPEUTICS INC | $10.92M | $0.00 | -$12.55M | -$12.58M | -$0.82 | N/A | N/A | N/A | N/A | |||
| MYO | MYOMO INC | $31.90M | $40.76M | -$7.41M | -$9.32M | -$0.22 | 93.07% | 59.13% | N/A | N/A | 2025-11-05 | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.94M | $4.17M | -$47.13M | -$50.71M | -$26.46 | -62.68% | N/A | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $47.81M | $0.00 | -$83.78M | -$85.96M | -$2.24 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.53M | $0.00 | -$14.99M | -$13.10M | -$0.58 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $21.38M | $0.00 | -$17.32M | -$17.96M | -$4.10 | N/A | N/A | N/A | N/A | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $10.00M | $14.65M | -$9.25M | -$11.09M | -$6.64 | -19.32% | 6.35% | N/A | N/A | |||
| CRIS | CURIS INC | $22.75M | $11.41M | -$37.53M | -$38.92M | -$4.74 | 12.24% | 0.34% | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $71.76M | $0.00 | -$13.72M | -$16.25M | -$0.79 | N/A | N/A | N/A | N/A | |||
| CYBN | CYBIN INC | $140.27M | $0.00 | -$89.45M | -$89.73M | -$4.34 | N/A | N/A | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $45.27M | $868.00k | -$34.61M | -$50.95M | -$11.94 | -63.88% | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $22.25M | $0.00 | -$55.01M | -$56.86M | -$18.16 | N/A | N/A | N/A | N/A | |||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | $0.00 | -$27.19M | -$27.41M | -$0.34 | N/A | N/A | N/A | N/A | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.51M | $0.00 | -$12.97M | -$41.91M | -$66.53 | N/A | N/A | N/A | N/A | |||
| LGVN | LONGEVERON INC | $11.96M | $2.07M | -$17.38M | -$18.69M | -$0.92 | 68.67% | N/A | N/A | N/A | 2025-11-12 | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.33M | $0.00 | -$24.46M | -$26.82M | -$21.31 | N/A | N/A | N/A | N/A | |||
| AMTX | AEMETIS INC | $136.60M | $223.57M | -$41.85M | -$82.06M | -$1.57 | -19.77% | 2.58% | N/A | N/A | 2025-11-12 | ||
| SLN | SILENCE THERAPEUTICS PLC | $212.81M | $27.37M | -$73.76M | -$79.40M | N/A | 21.64% | 73.57% | N/A | N/A | 2025-11-13 | ||
| IPSC | CENTURY THERAPEUTICS INC | $43.28M | $114.13M | -$7.37M | -$23.28M | -$0.29 | 5,489.03% | N/A | N/A | N/A | 2025-11-06 | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $250.73M | $0.00 | -$223.22M | -$236.91M | -$1.11 | -100.00% | N/A | N/A | N/A | 2025-10-30 | ||
| CABA | CABALETTA BIO INC | $93.37M | $0.00 | -$121.62M | -$126.76M | -$2.54 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| ATOS | ATOSSA THERAPEUTICS INC | $108.50M | $0.00 | -$28.70M | -$28.72M | -$0.23 | N/A | N/A | N/A | N/A | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $62.29M | $0.00 | -$72.62M | -$75.13M | -$1.27 | -100.00% | N/A | N/A | N/A | |||
| NKTX | NKARTA INC | $139.92M | $0.00 | -$97.90M | -$109.24M | -$1.47 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| ACET | ADICET BIO INC | $66.99M | $0.00 | -$107.56M | -$117.32M | -$1.29 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| CNTX | CONTEXT THERAPEUTICS INC | $74.90M | $0.00 | -$34.10M | -$34.21M | -$0.36 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| HUMA | HUMACYTE INC | $232.81M | $818.00k | -$40.80M | -$58.66M | -$0.45 | N/A | N/A | N/A | N/A | 2025-11-07 | ||
| OCGN | OCUGEN INC | $312.77M | $4.75M | -$50.68M | -$56.94M | -$0.20 | -34.54% | 156.28% | N/A | N/A | 2025-11-07 | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $63.37M | $1.00M | -$160.41M | -$183.87M | -$8.88 | N/A | 31.95% | N/A | N/A | |||
| FBRX | FORTE BIOSCIENCES INC | $131.29M | $0.00 | -$42.40M | -$42.45M | -$3.69 | N/A | N/A | N/A | N/A | |||
| NOTE | FISCALNOTE HOLDINGS INC | $65.58M | $109.68M | -$24.45M | -$45.84M | -$3.84 | -15.39% | N/A | N/A | N/A | |||
| SNTI | SENTI BIOSCIENCES INC | $35.21M | $0.00 | -$49.48M | -$54.79M | -$10.79 | -100.00% | N/A | N/A | N/A | |||
| ABOS | ACUMEN PHARMACEUTICALS INC | $79.96M | $0.00 | -$132.35M | -$136.67M | -$2.28 | N/A | N/A | N/A | N/A | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $367.28M | $29.93M | -$227.48M | -$227.78M | -$0.84 | 185.17% | 89.13% | N/A | N/A | 2025-10-30 | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $30.06M | $0.00 | -$27.07M | -$27.11M | -$0.65 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.